2023 Prescription Side effects 
pharmaphorum
JANUARY 6, 2023
In 2023, expect manufacturers to further shift their focus away from acquiring new patient prescriptions to retaining existing customers. The account carried an official blue check mark, but in fact it did not belong to the prescription drugmaker. in 1979 to 2.8%in Ensuring patient access.
PM360
DECEMBER 14, 2023
Survey any physician if they’ve been asked by a patient about a prescription weight loss medication and you’ll hear a resounding “yes.” The recent Sermo Barometer confirms that 89% of 300+ global practitioners have seen an increase in patients proactively requesting prescription weight loss medications.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
JANUARY 24, 2025
Advertisers want to engage audiences, but at the same time, need to adhere to updated FDA guidance released in November of 2023 for pharmaceutical ads. This guidance emphasizes clear presentation of risk information and ensures that, among other criteria, music in ads is not a distraction.
PM360
SEPTEMBER 21, 2023
Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.
PM360
AUGUST 9, 2022
The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. The Andaman7 Platform Solution. Vincent Keunen.
European Pharmaceutical Review
OCTOBER 17, 2024
Additionally, EURneffy could alleviate the risk of accidental needle-related side effects (such as injection into the blood vessel and hand) 3 and it has the attributes of being smaller in size, has better temperature sensitivity, and is less complex to use compared to needle-based injectors. Derived from IQVIA Claims Data, 2023.
PM360
JULY 13, 2023
2021 revealed that roughly one in four prescriptions were never filled. 1 Patients may discontinue if they cannot afford their out-of-pocket costs even with insurance coverage due to side effects or lack of perceived need for the medication itself. Novartis’ analysis of claims data from Nov. 2020 to Oct.
Expert insights. Personalized for you.
105 
Let's personalize your content